76 tracked 13F filers disclose a position in GALT as of the latest SEC 13F filings, a combined $35.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | $5.5M | 2.0M | →First observed position No prior filed position | Q1 2026 | |
| 2 | MARSHALL WACE, LLP | $3.4M | 1.2M | ▲+103% Added · +618K sh | Q1 2026 | |
| 3 | OSAIC HOLDINGS, INC. | $3.1M | 1.1M | ▲+2.9% Added · +32K sh | Q1 2026 | |
| 4 | BlackRock, Inc. | $2.2M | 799K | ▲+0.3% Added · +3K sh | Q1 2026 | |
| 5 | MILLENNIUM MANAGEMENT LLC | $2.2M | 798K | ▲+239% Added · +563K sh | Q1 2026 | |
| 6 | Wealthspire Advisors, LLC | $2.0M | 722K | ▲+20% Added · +120K sh | Q1 2026 | |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $1.7M | 613K | ▲+2.5% Added · +15K sh | Q1 2026 | |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.6M | 556K | ▲+94% Added · +269K sh | Q1 2026 | |
| 9 | TWO SIGMA INVESTMENTS, LP | $1.3M | 467K | ▲28× Added · +450K sh | Q1 2026 | |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | $1.0M | 367K | ▲+9.9% Added · +33K sh | Q1 2026 | |
| 11 | VANGUARD FIDUCIARY TRUST CO | $849K | 304K | →First observed position No prior filed position | Q1 2026 | |
| 12 | CITADEL ADVISORS LLC | $810K | 290K | ▲Added Added · +290K sh | Q1 2026 | |
| 13 | LPL Financial LLC | $745K | 267K | ▼−18% Reduced · −58K sh | Q1 2026 | |
| 14 | STATE STREET CORP | $721K | 258K | ▲+6.7% Added · +16K sh | Q1 2026 | |
| 15 | Geneos Wealth Management Inc. | $672K | 241K | ▼−1.0% Reduced · −2K sh | Q1 2026 | |
| 16 | JANE STREET GROUP, LLC | $544K | 195K | ▼−2.2% Reduced · −4K sh | Q1 2026 | |
| 17 | GOLDMAN SACHS GROUP INC | $515K | 185K | ▼−40% Reduced · −122K sh | Q1 2026 | |
| 18 | UBS Group AG | $501K | 180K | ▲+360% Added · +141K sh | Q1 2026 | |
| 19 | 683 Capital Management, LLC | $453K | 162K | —Held | Q1 2026 | |
| 20 | BLAIR WILLIAM & CO/IL | $417K | 149K | ▲+294% Added · +111K sh | Q1 2026 | |
| 21 | RENAISSANCE TECHNOLOGIES LLC | $413K | 148K | ▲New +148K sh | Q1 2026 | |
| 22 | NORTHERN TRUST CORP | $364K | 130K | —Held | Q1 2026 | |
| 23 | Qube Research & Technologies Ltd | $353K | 126K | ▲+69% Added · +52K sh | Q1 2026 | |
| 24 | BARCLAYS PLC | $312K | 112K | ▲+5.1% Added · +5K sh | Q1 2026 | |
| 25 | Belpointe Asset Management LLC | $296K | 106K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in GALT and 6 added to an existing one, while 6 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ALPHABET INC-CL AGOOGL | 29 funds | $6.4B |
| ELI LILLY & COLLY | 29 funds | $2.8B |
| UNITEDHEALTH GROUP INCUNH | 29 funds | $1.1B |
| BOOKING HOLDINGS INCBKNG | 29 funds | $628.1M |
| NVIDIA CORPNVDA | 28 funds | $12.5B |
| MICROSOFT CORPMSFT | 28 funds | $10.0B |
| SS SPDR S&P 500 ETF TRUST-USSPY | 28 funds | $9.0B |
| AMAZON.COM INCAMZN | 28 funds | $8.3B |
| BROADCOM INCAVGO | 28 funds | $4.8B |
| JPMORGAN CHASE & COJPM | 28 funds | $4.5B |
| ALPHABET INC-CL CGOOG | 28 funds | $4.4B |
| META PLATFORMS INC-CLASS AMETA | 28 funds | $4.0B |
Ranked by how many of GALT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 16K | $83K |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 47K | $239K |
| Jun 29, 2026 | Shlevin Harold H. | Director | Sell (S) | 22K | $112K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 2K | $10K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 3K | $13K |
| Jun 26, 2026 | Shlevin Harold H. | Director | Sell (S) | 8K | $39K |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 8K | $24K |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 568 | $2K |
| Feb 6, 2026 | ELDRED KARY | Director | Buy (P) | 300 | $810 |
| Jan 6, 2026 | Jamil Khurram | Chief Medical Officer | Sell (S) | 21K | $78K |
| Jan 6, 2026 | CALLICUTT JACK W | Chief Financial Officer | Sell (S) | 20K | $75K |
| Jan 6, 2026 | LEWIS JOEL | President and CEO, Director | Sell (S) | 38K | $135K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GALT/capital-change-brief"
Use Arkolith's capital_change_brief for GALT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GALT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.